Working… Menu

CD19 Redirected Autologous T Cells for Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02277522
Recruitment Status : Terminated (unable to meet enrollment goal)
First Posted : October 29, 2014
Last Update Posted : November 9, 2017
Information provided by (Responsible Party):
University of Pennsylvania